• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

视网膜动脉阻塞的概况与预后:加快就诊的需求未得到充分认识。

Profile and outcomes of retinal artery occlusion: The underrealized need to expedite presentation.

作者信息

Kadam Yogita, Das Anthony V, Narayanan Raja, Balakrishnan Neelima, Telukunta Praneet, Takkar Brijesh

机构信息

Department of Eyesmart EMR and AEye, L. V. Prasad Eye Institute, Hyderabad, Telangana, India.

Indian Health Outcomes, Public Health, and Economics Research Center, L. V. Prasad Eye Institute, Hyderabad, Telangana, India.

出版信息

Indian J Ophthalmol. 2025 Jan 1;73(Suppl 1):S72-S77. doi: 10.4103/IJO.IJO_1686_24. Epub 2024 Dec 24.

DOI:10.4103/IJO.IJO_1686_24
PMID:39723868
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11834905/
Abstract

PURPOSE

To evaluate the clinical profile of retinal artery occlusion (RAO) and impact of presentation on visual outcomes.

DESIGN

A retrospective analysis of case files of 3070 patients with RAO was performed using electronic medical records.

METHODS

Demographic data were analyzed using descriptive statistics. The differential distribution of risk factors of RAO with age was studied. Time to presentation and treatment effects were assessed using multivariate regression. Interaction plots were drawn to assess the impact of risk factors on outcomes.

RESULTS

Central RAO was the most common type (n = 2443, 77.11%), followed by branch RAO (n = 500, 15.78%), while combined retinal vascular occlusion and cilio-RAO were rare. Most of the patients (71.40%) were male and had unilateral (96.81%) affliction. Almost half presented within the fifth (24.85%) and sixth (21.4%) decades of life. Hyperhomocysteinemia had a higher association (1.95, P = 0.0019) with younger patients (<40 years), while hypertension (3.64, P < 0.001), diabetes mellitus (DM; 4.18, P < 0.001), and coronary artery disease (CAD) (4.26, P = 0.002) were significantly commoner in older patients. CAD (5.1%) and cerebrovascular disease (0.6%) were detected after ocular presentation in some patients. Embolus, though detected rarely (1%), was associated (60%) with serious systemic disorders. Early presentation (<6 h) was associated with better visual outcomes (mean log of minimum angle of resolution 1.8 ± 1.3 vs. 2.1 ± 1.3, P = 0.032). Neovascular glaucoma (2.14% overall) was twice more common in DM (P < 0.0004) and led to further vision loss. Visual improvement occurred in 10% of patients over follow-up.

CONCLUSION

RAO occurs slightly earlier compared to coronary and cerebrovascular disorders and can precede their detection. Associated risk factors vary with the age of presentation. Presentation within 6 h needs facilitation for better outcomes and management.

摘要

目的

评估视网膜动脉阻塞(RAO)的临床特征以及就诊情况对视力预后的影响。

设计

利用电子病历对3070例RAO患者的病例档案进行回顾性分析。

方法

采用描述性统计分析人口统计学数据。研究RAO危险因素随年龄的差异分布。使用多因素回归评估就诊时间和治疗效果。绘制交互图以评估危险因素对预后的影响。

结果

中央性RAO是最常见的类型(n = 2443,77.11%),其次是分支性RAO(n = 500,15.78%),而视网膜血管联合阻塞和睫状视网膜动脉阻塞则较为罕见。大多数患者(71.40%)为男性,且为单侧患病(96.81%)。几乎一半的患者在第五个十年(24.85%)和第六个十年(21.4%)发病。高同型半胱氨酸血症在年轻患者(<40岁)中关联度更高(1.95,P = 0.0019),而高血压(3.64,P < 0.001)、糖尿病(DM;4.18,P < 0.001)和冠状动脉疾病(CAD)(4.26,P = 0.002)在老年患者中明显更为常见。部分患者在眼部发病后检测出CAD(5.1%)和脑血管疾病(0.6%)。栓子虽很少被检测到(1%),但与严重的全身性疾病相关(60%)。早期就诊(<6小时)与更好的视力预后相关(最小分辨角的平均对数1.8±1.3 vs. 2.1±1.3,P = 0.032)。新生血管性青光眼(总体为2.14%)在DM患者中更为常见(P < 0.0004),并导致视力进一步丧失。随访期间10%的患者视力有所改善。

结论

与冠状动脉和脑血管疾病相比,RAO发病稍早,且可能先于它们被发现。相关危险因素随发病年龄而异。6小时内就诊有助于获得更好的预后和治疗效果。

相似文献

1
Profile and outcomes of retinal artery occlusion: The underrealized need to expedite presentation.视网膜动脉阻塞的概况与预后:加快就诊的需求未得到充分认识。
Indian J Ophthalmol. 2025 Jan 1;73(Suppl 1):S72-S77. doi: 10.4103/IJO.IJO_1686_24. Epub 2024 Dec 24.
2
Retinal artery occlusion in young patients without typical cardiovascular risk factors: etiologies, prognosis, and suggested work-up.年轻患者无典型心血管危险因素的视网膜动脉阻塞:病因、预后和建议的检查。
Graefes Arch Clin Exp Ophthalmol. 2024 Nov;262(11):3577-3587. doi: 10.1007/s00417-024-06527-5. Epub 2024 Jun 7.
3
RETINAL ARTERY OCCLUSION AFTER INTRAVASCULAR PROCEDURES: Case Series and Literature Review.视网膜血管阻塞后的血管内治疗:病例系列及文献回顾。
Retina. 2019 Apr;39(4):766-778. doi: 10.1097/IAE.0000000000002008.
4
Multimodal Imaging Characteristics and Correlation to Outcomes in Patients With Central Retinal Artery Occlusion Presenting to a Large Academic Center.大型学术中心收治的视网膜中央动脉阻塞患者的多模态成像特征及其与预后的相关性
Am J Ophthalmol. 2025 Feb;270:35-51. doi: 10.1016/j.ajo.2024.10.004. Epub 2024 Oct 15.
5
Age, Gender, and Laterality of Retinal Vascular Occlusion: A Retrospective Study from the IRIS® Registry.年龄、性别和视网膜血管闭塞的侧别:来自 IRIS® 登记处的回顾性研究。
Ophthalmol Retina. 2022 Feb;6(2):161-171. doi: 10.1016/j.oret.2021.05.004. Epub 2021 May 12.
6
Combined branch retinal vein and branch retinal artery occlusion - clinical features, systemic associations, and outcomes.视网膜分支静脉与视网膜分支动脉联合阻塞——临床特征、全身相关性及预后
Indian J Ophthalmol. 2017 Mar;65(3):238-241. doi: 10.4103/ijo.IJO_340_16.
7
Circadian incidence of non-inflammatory retinal artery occlusions.非炎性视网膜动脉阻塞的昼夜发病率。
Graefes Arch Clin Exp Ophthalmol. 2009 Apr;247(4):491-4. doi: 10.1007/s00417-008-0989-y. Epub 2008 Nov 7.
8
Abnormal retinal vessel filling in central retinal artery occlusion.视网膜中央动脉阻塞时视网膜血管充盈异常。
Clin Exp Optom. 2024 Nov;107(8):801-805. doi: 10.1080/08164622.2023.2298781. Epub 2024 Jan 7.
9
Assessing the risk of stroke development following retinal artery occlusion.评估视网膜动脉阻塞后中风发展的风险。
J Stroke Cerebrovasc Dis. 2020 Sep;29(9):105002. doi: 10.1016/j.jstrokecerebrovasdis.2020.105002. Epub 2020 Jun 15.
10
Optical coherence tomography angiography characteristics of acute retinal arterial occlusion.急性视网膜动脉阻塞的光学相干断层扫描血管造影特征
BMC Ophthalmol. 2019 Jul 10;19(1):147. doi: 10.1186/s12886-019-1152-8.

本文引用的文献

1
The Impact of the Initial Admission Department on the Management and Prognosis of Retinal Artery Occlusion.首次收治科室对视网膜动脉阻塞治疗及预后的影响
Curr Neurovasc Res. 2022;19(5):440-448. doi: 10.2174/1567202620666221027091249.
2
Structural and Functional Imaging of the Retina in Central Retinal Artery Occlusion - Current Approaches and Future Directions.视网膜中央动脉阻塞的视网膜结构和功能成像 - 现有方法和未来方向。
J Stroke Cerebrovasc Dis. 2021 Jul;30(7):105828. doi: 10.1016/j.jstrokecerebrovasdis.2021.105828. Epub 2021 May 17.
3
Age, Gender, and Laterality of Retinal Vascular Occlusion: A Retrospective Study from the IRIS® Registry.
年龄、性别和视网膜血管闭塞的侧别:来自 IRIS® 登记处的回顾性研究。
Ophthalmol Retina. 2022 Feb;6(2):161-171. doi: 10.1016/j.oret.2021.05.004. Epub 2021 May 12.
4
Workup following retinal artery occlusion-experience from an outpatient retina clinic and the delay in workup.视网膜动脉阻塞的检查-来自一个门诊视网膜诊所的经验以及检查的延误。
Graefes Arch Clin Exp Ophthalmol. 2021 Sep;259(9):2625-2632. doi: 10.1007/s00417-021-05135-x. Epub 2021 Mar 12.
5
Retinal vascular occlusions.视网膜血管阻塞。
Lancet. 2020 Dec 12;396(10266):1927-1940. doi: 10.1016/S0140-6736(20)31559-2.
6
Characteristics and Outcomes of Retinal Artery Occlusion: Nationally Representative Data.视网膜动脉阻塞的特征和结局:全国代表性数据。
Stroke. 2020 Mar;51(3):800-807. doi: 10.1161/STROKEAHA.119.027034. Epub 2020 Jan 17.
7
Atrial Fibrillation: An Underestimated Cause of Ischemic Monocular Visual Loss?心房颤动:缺血性单眼视力丧失的一个被低估的原因?
J Stroke Cerebrovasc Dis. 2019 Jun;28(6):1495-1499. doi: 10.1016/j.jstrokecerebrovasdis.2019.03.017. Epub 2019 Mar 29.
8
Central retinal artery occlusion.视网膜中央动脉阻塞。
Indian J Ophthalmol. 2018 Dec;66(12):1684-1694. doi: 10.4103/ijo.IJO_1446_18.
9
Risk of retinal artery occlusion in patients with diabetes mellitus: A retrospective large-scale cohort study.糖尿病患者视网膜动脉阻塞的风险:一项回顾性大规模队列研究。
PLoS One. 2018 Aug 9;13(8):e0201627. doi: 10.1371/journal.pone.0201627. eCollection 2018.
10
Risk of incident atrial fibrillation in patients presenting with retinal artery or vein occlusion: a nationwide cohort study.视网膜动脉或静脉阻塞患者发生心房颤动的风险:一项全国性队列研究。
BMC Cardiovasc Disord. 2018 May 10;18(1):91. doi: 10.1186/s12872-018-0825-1.